Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.


Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at


Neurodegenerative disorders are the leading cause of physical and cognitive disability worldwide, affecting approximately 15% of the global population. Neuroinflammation is not only a hallmark of neurodegenerative diseases, but a prominent and active contributor to disease progression. Therefore, therapeutics dampening neuroinflammation hold significant promise for the treatment of several neurodegenerative diseases.

Connected servicesMore informationSpeak to an expert

Connected expertise and services

A more in-depth view

Neurodegenerative diseases are characterised by a state of chronic inflammation of the nervous system, termed neuroinflammation. Neuroinflammation is not simply a consequence of the tissue damage that occurs in neurodegenerative diseases, but a driver of disease progression. The full range of contributing factors and biological mechanisms that drive neuroinflammation is not fully elucidated, which is why there is value in having access to a range of biological models of increasing complexity to support the discovery of novel drugs in this space.

We offer a range of biological models and cutting-edge instrumentation to support drug discovery in neuroinflammation:

  • Diverse Biological Systems: By utilising human and rodent models of increasing complexity, from cell cultures to 3D systems, we can support your drug discovery efforts.
  • A Range of Advanced Technologies: such as High-Content Imaging for in-depth phenotypic characterisation.
Our Capabilities:
  • Inflammatory Polarisation: Evaluating microglial and astrocytic inflammatory responses.
  • Inflammasome Activation: Assessing activation of the inflammasome, a key component of inflammatory responses.
  • Microglial Function: Assessing phagocytosis and migration abilities.
  • Neurotoxicity/Neuroprotection: Determining the impact on neuronal health and function.

These approaches and capabilities collectively contribute to a comprehensive understanding of neuroinflammation and aid in developing potential treatments for neurodegenerative diseases.

Connected resources